BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32084588)

  • 1. Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.
    Kim JH; Shim SH; Nam SH; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT
    J Minim Invasive Gynecol; 2020; 27(7):1558-1565. PubMed ID: 32084588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
    Wang R; Xiao Y; Ma L; Wu Z; Xia H
    Gynecol Obstet Invest; 2022; 87(6):398-405. PubMed ID: 36273460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes.
    Brandt B; Sioulas V; Basaran D; Kuhn T; LaVigne K; Gardner GJ; Sonoda Y; Chi DS; Long Roche KC; Mueller JJ; Jewell EL; Broach VA; Zivanovic O; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Mar; 156(3):591-597. PubMed ID: 31918996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: A real-world multicenter study of a large Chinese cohort from 2006 to 2017.
    Guo C; Tang X; Meng Y; Zhang Y; Zhang X; Guo J; Lei X; Qiu J; Hua K
    Cancer Med; 2020 Aug; 9(16):5908-5921. PubMed ID: 32628356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO Staging.
    Levine MD; Brown J; Crane EK; Tait DL; Naumann RW
    J Minim Invasive Gynecol; 2021 Apr; 28(4):824-828. PubMed ID: 32730990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score-matched cohort study.
    Dai D; Huang H; Feng Y; Wan T; Liu Z; Tong C; Liu J
    Cancer Med; 2020 Dec; 9(24):9236-9245. PubMed ID: 33236825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan.
    Ohta T; Nagase S; Okui Y; Enomoto T; Yamagami W; Mikami M; Tokunaga H; Ino K; Ushijima K; Shozu M; Tashiro H; Mandai M; Miyamoto S; Morishige KI; Yoshida Y; Yoshino K; Saito T; Kobayashi E; Kobayashi H; Takekuma M; Terai Y; Fujii T; Kanao H; Aoki D; Katabuchi H; Yaegashi N
    Int J Clin Oncol; 2021 Dec; 26(12):2318-2330. PubMed ID: 34435284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
    Kim Y; Kim SI; Kim H; Lee M; Kim HS; Kim K; Chung HH; No JH; Kim YB; Kim JW; Park NH; Song YS; Lee C; Suh DH
    Gynecol Oncol; 2022 Oct; 167(1):28-36. PubMed ID: 35970602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes.
    Yang EJ; Kim NR; Lee AJ; Shim SH; Lee SJ
    Medicine (Baltimore); 2022 Feb; 101(8):e28911. PubMed ID: 35212297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?
    Nica A; Kim SR; Gien LT; Covens A; Bernardini MQ; Bouchard-Fortier G; Kupets R; May T; Vicus D; Laframboise S; Hogen L; Cusimano MC; Ferguson SE
    Int J Gynecol Cancer; 2020 Dec; 30(12):1864-1870. PubMed ID: 33037109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence and survival in neuroendocrine cervical cancer.
    Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M
    Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
    Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
    Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally Invasive Radical Hysterectomy for Cervical Cancer Is Associated With Reduced Morbidity and Similar Survival Outcomes Compared With Laparotomy.
    Diver E; Hinchcliff E; Gockley A; Melamed A; Contrino L; Feldman S; Growdon W
    J Minim Invasive Gynecol; 2017; 24(3):402-406. PubMed ID: 28011096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.
    Chiva L; Zanagnolo V; Querleu D; Martin-Calvo N; Arévalo-Serrano J; Căpîlna ME; Fagotti A; Kucukmetin A; Mom C; Chakalova G; Aliyev S; Malzoni M; Narducci F; Arencibia O; Raspagliesi F; Toptas T; Cibula D; Kaidarova D; Meydanli MM; Tavares M; Golub D; Perrone AM; Poka R; Tsolakidis D; Vujić G; Jedryka MA; Zusterzeel PLM; Beltman JJ; Goffin F; Haidopoulos D; Haller H; Jach R; Yezhova I; Berlev I; Bernardino M; Bharathan R; Lanner M; Maenpaa MM; Sukhin V; Feron JG; Fruscio R; Kukk K; Ponce J; Minguez JA; Vázquez-Vicente D; Castellanos T; Chacon E; Alcazar JL;
    Int J Gynecol Cancer; 2020 Sep; 30(9):1269-1277. PubMed ID: 32788262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.